Transforming women’s health
Revolutionizing Pelvic Organ Prolapse Care
Tissue Lifting & Tensioning (TLT) delivers a minimally invasive, 10-minute solution that restores anatomy without bulky implants or permanent mesh.
The Arcus TLT Solution
Tissue Lifting & Tensioning designed for outpatient success
The Arcus TLT device restores anatomical support through a minimally invasive approach that pairs clinical simplicity with strong procedural economics.
TLT device positioning with clinical illustration style.
Why Now?
The perfect storm of market need, regulatory opportunity, and clinical demand
Arcus Medical is positioned for rapid adoption as surgeons seek minimally invasive alternatives to transvaginal mesh.
Massive Unmet Need
6.6M U.S. women suffer from POP; 88% remain untreated due to lack of minimally invasive options.
FDA Created Vacuum
Removal of transvaginal mesh opened a gap for safer, office-based innovation.
Immediate Reimbursement
Existing CPT codes (57240/50/60) enable reimbursement from day one.
Office-Based Care
No modern office or ASC solution exists today. Arcus fills the gap.
The TLT 3-Step Process
Patented simplicity for rapid adoption and consistent outcomes
Access
Minimally invasive access to the treatment area through a precise, controlled approach.
Capture
Proprietary mechanism captures and positions prolapsed tissue with controlled tension.
Fixate
Secure fixation restores normal anatomy and provides durable support.
Anatomical Restoration
TLT restores normal pelvic anatomy without synthetic mesh
Before TLT
After TLT
Massive Market Opportunity
Everyone serves the 12% — we serve the 88%
Total addressable market
Women globally affected by pelvic organ prolapse.
Serviceable addressable market
U.S. women seeking treatment options.
Serviceable obtainable market
Untreated women — the primary 88% segment.
Investment Highlights
Raising $1.5M seed to complete trials, regulatory prep, and early commercialization
Large Unmet Need
Only a small fraction of POP patients undergo surgical repair. Millions actively seek minimally invasive alternatives.
Proprietary Device
Patented TLT technology with U.S. filings and global markets planned. Protected IP position.
Existing CPT Reimbursement
Procedure aligns with established CPT codes, enabling immediate payment pathways.
Clear Exit Path
Strategic acquisition targets across women’s health and medtech portfolios.
Partner with Arcus Medical
Join us in transforming women’s health
Schedule a conversation to review clinical progress, investment materials, or partnership opportunities.